Literature DB >> 23956119

Specific glial functions contribute to schizophrenia susceptibility.

Andrea Goudriaan1, Christiaan de Leeuw2, Stephan Ripke3, Christina M Hultman4, Pamela Sklar5, Patrick F Sullivan6, August B Smit7, Danielle Posthuma8, Mark H G Verheijen7.   

Abstract

Schizophrenia is a highly polygenic brain disorder. The main hypothesis for disease etiology in schizophrenia primarily focuses on the role of dysfunctional synaptic transmission. Previous studies have therefore directed their investigations toward the role of neuronal dysfunction. However, recent studies have shown that apart from neurons, glial cells also play a major role in synaptic transmission. Therefore, we investigated the potential causal involvement of the 3 principle glial cell lineages in risk to schizophrenia. We performed a functional gene set analysis to test for the combined effects of genetic variants in glial type-specific genes for association with schizophrenia. We used genome-wide association data from the largest schizophrenia sample to date, including 13 689 cases and 18 226 healthy controls. Our results show that astrocyte and oligodendrocyte gene sets, but not microglia gene sets, are associated with an increased risk for schizophrenia. The astrocyte and oligodendrocyte findings are related to astrocyte signaling at the synapse, myelin membrane integrity, glial development, and epigenetic control. Together, these results show that genetic alterations underlying specific glial cell type functions increase susceptibility to schizophrenia and provide evidence that the neuronal hypothesis of schizophrenia should be extended to include the role of glia.
© The Author 2013. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  GWAS; PGC; gene set analysis; genome-wide association; glia; psychiatric disease

Mesh:

Year:  2013        PMID: 23956119      PMCID: PMC4059439          DOI: 10.1093/schbul/sbt109

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  66 in total

Review 1.  The application of DTI to investigate white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Carl-Fredrik Westin; Robert W McCarley; Martha E Shenton
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

Review 2.  Microarrays and expression profiling in microglia research and in inflammatory brain disorders.

Authors:  Peter J Gebicke-Haerter
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

3.  Recurrence risks for schizophrenia in a Swedish national cohort.

Authors:  Paul Lichtenstein; Camilla Björk; Christina M Hultman; Edward Scolnick; Pamela Sklar; Patrick F Sullivan
Journal:  Psychol Med       Date:  2006-07-25       Impact factor: 7.723

Review 4.  Roles of glial cells in schizophrenia: possible targets for therapeutic approaches.

Authors:  Nagahide Takahashi; Takeshi Sakurai
Journal:  Neurobiol Dis       Date:  2012-11-09       Impact factor: 5.996

5.  Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity.

Authors:  Zul Merali; Tania Bédard; Nick Andrews; Ben Davis; Alexander T McKnight; M Isabel Gonzalez; Martyn Pritchard; Pam Kent; Hymie Anisman
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

Review 6.  Astrocytes, from brain glue to communication elements: the revolution continues.

Authors:  Andrea Volterra; Jacopo Meldolesi
Journal:  Nat Rev Neurosci       Date:  2005-08       Impact factor: 34.870

7.  Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia.

Authors:  E S Lips; L N Cornelisse; R F Toonen; J L Min; C M Hultman; P A Holmans; M C O'Donovan; S M Purcell; A B Smit; M Verhage; P F Sullivan; P M Visscher; D Posthuma
Journal:  Mol Psychiatry       Date:  2011-09-20       Impact factor: 15.992

8.  The Stanford Microarray Database: implementation of new analysis tools and open source release of software.

Authors:  Janos Demeter; Catherine Beauheim; Jeremy Gollub; Tina Hernandez-Boussard; Heng Jin; Donald Maier; John C Matese; Michael Nitzberg; Farrell Wymore; Zachariah K Zachariah; Patrick O Brown; Gavin Sherlock; Catherine A Ball
Journal:  Nucleic Acids Res       Date:  2006-12-20       Impact factor: 16.971

9.  Plasticity of astrocytic coverage and glutamate transporter expression in adult mouse cortex.

Authors:  Christel Genoud; Charles Quairiaux; Pascal Steiner; Harald Hirling; Egbert Welker; Graham W Knott
Journal:  PLoS Biol       Date:  2006-10       Impact factor: 8.029

10.  GeneTools--application for functional annotation and statistical hypothesis testing.

Authors:  Vidar Beisvag; Frode K R Jünge; Hallgeir Bergum; Lars Jølsum; Stian Lydersen; Clara-Cecilie Günther; Heri Ramampiaro; Mette Langaas; Arne K Sandvik; Astrid Laegreid
Journal:  BMC Bioinformatics       Date:  2006-10-24       Impact factor: 3.169

View more
  51 in total

1.  Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia.

Authors:  Hans-Gert Bernstein; Esther Jauch; Henrik Dobrowolny; Christian Mawrin; Johann Steiner; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-28       Impact factor: 5.270

2.  Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy.

Authors:  Karmela Sobczyk; Markus S Jördens; Ayse Karababa; Boris Görg; Dieter Häussinger
Journal:  Neurochem Res       Date:  2014-07-27       Impact factor: 3.996

3.  Involvement of astrocyte metabolic coupling in Tourette syndrome pathogenesis.

Authors:  Christiaan de Leeuw; Andrea Goudriaan; August B Smit; Dongmei Yu; Carol A Mathews; Jeremiah M Scharf; Mark H G Verheijen; Danielle Posthuma
Journal:  Eur J Hum Genet       Date:  2015-03-04       Impact factor: 4.246

Review 4.  Maternal immune activation and abnormal brain development across CNS disorders.

Authors:  Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

5.  Cell Type-Specific Effects of Mutant DISC1: A Proteomics Study.

Authors:  Meng Xia; Jantine A C Broek; Yan Jouroukhin; Jeannine Schoenfelder; Sofya Abazyan; Hanna Jaaro-Peled; Akira Sawa; Sabine Bahn; Mikhail Pletnikov
Journal:  Mol Neuropsychiatry       Date:  2016-04-01

Review 6.  Glial evolution as a determinant of human behavior and its disorders.

Authors:  Steven A Goldman
Journal:  Ann N Y Acad Sci       Date:  2020-05-25       Impact factor: 5.691

Review 7.  Dysregulation of miRNA and its potential therapeutic application in schizophrenia.

Authors:  Ting Cao; Xue-Chu Zhen
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

Review 8.  Cannabinoids and glial cells: possible mechanism to understand schizophrenia.

Authors:  Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-01       Impact factor: 5.270

9.  Strain Differences in Presynaptic Function: PROTEOMICS, ULTRASTRUCTURE, AND PHYSIOLOGY OF HIPPOCAMPAL SYNAPSES IN DBA/2J AND C57Bl/6J MICE.

Authors:  A Mariette Lenselink; Diana C Rotaru; Ka Wan Li; Pim van Nierop; Priyanka Rao-Ruiz; Maarten Loos; Roel van der Schors; Yvonne Gouwenberg; Joke Wortel; Huibert D Mansvelder; August B Smit; Sabine Spijker
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

10.  Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.

Authors:  Eric Plitman; Camilo de la Fuente-Sandoval; Francisco Reyes-Madrigal; Sofia Chavez; Gladys Gómez-Cruz; Pablo León-Ortiz; Ariel Graff-Guerrero
Journal:  Schizophr Bull       Date:  2015-08-28       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.